Evidence map›Paper›PMID 36278052›Full record

ArticleACS omega2022

Vicinal Diaryl-Substituted Isoxazole and Pyrazole Derivatives with

Sümeyye Turanlı, Esra Nalbat, Deniz Lengerli, Kübra İbiş, Sezen Güntekin Ergün, Ece Akhan Güzelcan, Mesut Muyan, Rengul Cetin-Atalay, Burcu Çalışkan, Erden Banoglu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Facile synthesis andFuture medicinal chemistry · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sümeyye TuranlıDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Gazi University, Yenimahalle, Ankara 06560, Turkey.
Esra NalbatCancer Systems Biology Laboratory, Graduate School of Informatics, Middle East Technical University, Ankara 06800, Turkey.
Deniz LengerliDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Gazi University, Yenimahalle, Ankara 06560, Turkey.ORCID https://orcid.org/0000-0001-9838-8995
Kübra İbişDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Gazi University, Yenimahalle, Ankara 06560, Turkey.ORCID https://orcid.org/0000-0002-6898-0258
Sezen Güntekin ErgünCancer Systems Biology Laboratory, Graduate School of Informatics, Middle East Technical University, Ankara 06800, Turkey.
Ece Akhan GüzelcanCancer Systems Biology Laboratory, Graduate School of Informatics, Middle East Technical University, Ankara 06800, Turkey.
Mesut MuyanDepartment of Biological Sciences, Middle East Technical University, Ankara 06800, Turkey.
Rengul Cetin-AtalayCancer Systems Biology Laboratory, Graduate School of Informatics, Middle East Technical University, Ankara 06800, Turkey.
Burcu ÇalışkanDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Gazi University, Yenimahalle, Ankara 06560, Turkey.ORCID https://orcid.org/0000-0003-2391-5644
Erden BanogluDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Gazi University, Yenimahalle, Ankara 06560, Turkey.ORCID https://orcid.org/0000-0003-4737-1733

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The vicinal diaryl heterocyclic framework has been widely used for the development of compounds with significant bioactivities. In this study, a series of diaryl heterocycles were designed and synthesized based on an in-house diaryl isoxazole derivative (

Identifiers

PMID36278052
PMCPMC9583322

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.